FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026205451> ?p ?o ?g. }

• W2026205451 endingPage "2647" @default.
• W2026205451 startingPage "2638" @default.
• W2026205451 abstract "In radiation therapy of pancreatic cancer, tumor alignment prior to each treatment fraction is improved when intratumoral gold fiducial markers (from here onwards: markers), which are visible on computed tomography (CT) and cone beam CT, are used. Visibility of these markers on magnetic resonance imaging (MRI) might improve image registration between CT and magnetic resonance (MR) images for tumor delineation purposes. However, concomitant image artifacts induced by markers are undesirable. The extent of visibility and artifact size depend on MRI-sequence parameters. The authors' goal was to determine for various markers their potential to be visible and to generate artifacts, using measures that are independent of the MRI-sequence parameters.The authors selected ten different markers suitable for endoscopic placement in the pancreas and placed them into a phantom. The markers varied in diameter (0.28-0.6 mm), shape, and iron content (0%-0.5%). For each marker, the authors calculated T2 (∗)-maps and ΔB0-maps using MRI measurements. A decrease in relaxation time T2 (∗) can cause signal voids, associated with visibility, while a change in the magnetic field B0 can cause signal shifts, which are associated with artifacts. These shifts inhibit accurate tumor delineation. As a measure for potential visibility, the authors used the volume of low T2 (∗), i.e., the volume for which T2 (∗) differed from the background by >15 ms. As a measure for potential artifacts, the authors used the volume for which |ΔB0| > 9.4 × 10(-8) T (4 Hz). To test whether there is a correlation between visibility and artifact size, the authors calculated the Spearman's correlation coefficient (Rs) between the volume of low T2 (∗) and the volume of high |ΔB0|. The authors compared the maps with images obtained using a clinical MR-sequence. Finally, for the best visible marker as well as the marker that showed the smallest artifact, the authors compared the phantom data with in vivo MR-images in four pancreatic cancer patients.The authors found a strong correlation (Rs = 1.00, p < 0.01) between the volume of low T2 (∗) and the volume with high |ΔB0|. Visibility in clinical MR-images increased with lower T2 (∗). Signal shift artifacts became worse for markers with high |ΔB0|. The marker that was best visible in the phantom, a folded marker with 0.5% iron content, was also visible in vivo, but showed artifacts on diffusion weighted images. The marker with the smallest artifact in the phantom, a small, stretched, ironless marker, was indiscernible on in vivo MR-images.Changes in T2 (∗) and ΔB0 are sequence-independent measures for potential visibility and artifact size, respectively. Improved visibility of markers correlates strongly to signal shift artifacts; therefore, marker choice will depend on the clinical purpose. When visibility of the markers is most important, markers that contain iron are optimal, preferably in a folded configuration. For artifact sensitive imaging, small ironless markers are best, preferably in a stretched configuration." @default.
• W2026205451 created "2016-06-24" @default.
• W2026205451 creator A5001020783 @default.
• W2026205451 creator A5016784441 @default.
• W2026205451 creator A5022556537 @default.
• W2026205451 creator A5033788401 @default.
• W2026205451 creator A5060506055 @default.
• W2026205451 creator A5060970719 @default.
• W2026205451 creator A5070504139 @default.
• W2026205451 creator A5074911126 @default.
• W2026205451 creator A5082565853 @default.
• W2026205451 creator A5091390590 @default.
• W2026205451 date "2015-05-01" @default.
• W2026205451 modified "2023-10-16" @default.
• W2026205451 title "Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI" @default.
• W2026205451 cites W1964318214 @default.
• W2026205451 cites W1968361769 @default.
• W2026205451 cites W1978134131 @default.
• W2026205451 cites W1986437398 @default.
• W2026205451 cites W1987641546 @default.
• W2026205451 cites W1994848481 @default.
• W2026205451 cites W2001853910 @default.
• W2026205451 cites W2002254976 @default.
• W2026205451 cites W2015153032 @default.
• W2026205451 cites W2029711674 @default.
• W2026205451 cites W2053359159 @default.
• W2026205451 cites W2061894200 @default.
• W2026205451 cites W2072274183 @default.
• W2026205451 cites W2075557470 @default.
• W2026205451 cites W2082754546 @default.
• W2026205451 cites W2084581394 @default.
• W2026205451 cites W2085123924 @default.
• W2026205451 cites W2095373083 @default.
• W2026205451 cites W2097723467 @default.
• W2026205451 cites W2102416888 @default.
• W2026205451 cites W2103660681 @default.
• W2026205451 cites W2107910612 @default.
• W2026205451 cites W2115557151 @default.
• W2026205451 cites W2130124777 @default.
• W2026205451 cites W2133716075 @default.
• W2026205451 cites W2137642294 @default.
• W2026205451 cites W2138620959 @default.
• W2026205451 cites W2159009218 @default.
• W2026205451 cites W2160506967 @default.
• W2026205451 doi "https://doi.org/10.1118/1.4918753" @default.
• W2026205451 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25979055" @default.
• W2026205451 hasPublicationYear "2015" @default.
• W2026205451 type Work @default.
• W2026205451 sameAs 2026205451 @default.
• W2026205451 citedByCount "42" @default.
• W2026205451 countsByYear W20262054512016 @default.
• W2026205451 countsByYear W20262054512017 @default.
• W2026205451 countsByYear W20262054512018 @default.
• W2026205451 countsByYear W20262054512019 @default.
• W2026205451 countsByYear W20262054512020 @default.
• W2026205451 countsByYear W20262054512021 @default.
• W2026205451 countsByYear W20262054512022 @default.
• W2026205451 countsByYear W20262054512023 @default.
• W2026205451 crossrefType "journal-article" @default.
• W2026205451 hasAuthorship W2026205451A5001020783 @default.
• W2026205451 hasAuthorship W2026205451A5016784441 @default.
• W2026205451 hasAuthorship W2026205451A5022556537 @default.
• W2026205451 hasAuthorship W2026205451A5033788401 @default.
• W2026205451 hasAuthorship W2026205451A5060506055 @default.
• W2026205451 hasAuthorship W2026205451A5060970719 @default.
• W2026205451 hasAuthorship W2026205451A5070504139 @default.
• W2026205451 hasAuthorship W2026205451A5074911126 @default.
• W2026205451 hasAuthorship W2026205451A5082565853 @default.
• W2026205451 hasAuthorship W2026205451A5091390590 @default.
• W2026205451 hasConcept C104293457 @default.
• W2026205451 hasConcept C115961682 @default.
• W2026205451 hasConcept C120665830 @default.
• W2026205451 hasConcept C121332964 @default.
• W2026205451 hasConcept C121608353 @default.
• W2026205451 hasConcept C123403432 @default.
• W2026205451 hasConcept C126322002 @default.
• W2026205451 hasConcept C126838900 @default.
• W2026205451 hasConcept C143409427 @default.
• W2026205451 hasConcept C154945302 @default.
• W2026205451 hasConcept C166704113 @default.
• W2026205451 hasConcept C173974348 @default.
• W2026205451 hasConcept C2779010991 @default.
• W2026205451 hasConcept C2780210213 @default.
• W2026205451 hasConcept C2989005 @default.
• W2026205451 hasConcept C31601959 @default.
• W2026205451 hasConcept C41008148 @default.
• W2026205451 hasConcept C71924100 @default.
• W2026205451 hasConcept C9267231 @default.
• W2026205451 hasConceptScore W2026205451C104293457 @default.
• W2026205451 hasConceptScore W2026205451C115961682 @default.
• W2026205451 hasConceptScore W2026205451C120665830 @default.
• W2026205451 hasConceptScore W2026205451C121332964 @default.
• W2026205451 hasConceptScore W2026205451C121608353 @default.
• W2026205451 hasConceptScore W2026205451C123403432 @default.
• W2026205451 hasConceptScore W2026205451C126322002 @default.
• W2026205451 hasConceptScore W2026205451C126838900 @default.
• W2026205451 hasConceptScore W2026205451C143409427 @default.
• W2026205451 hasConceptScore W2026205451C154945302 @default.

• next